Cargando…
Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece
Autores principales: | Vlachoyiannopoulos, Panayiotis, Alexopoulos, Haris, Apostolidi, Irini, Bitzogli, Kleopatra, Barba, Chrysanthi, Athanasopoulou, Elpida, Dalakas, Marinos, Tzioufas, Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590810/ https://www.ncbi.nlm.nih.gov/pubmed/33127563 http://dx.doi.org/10.1016/j.clim.2020.108619 |
Ejemplares similares
-
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
por: Alexopoulos, Harry, et al.
Publicado: (2020) -
Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
por: Dalakas, Marinos C., et al.
Publicado: (2021) -
Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al
por: Bakasis, Athanasios‐Dimitrios, et al.
Publicado: (2022) -
Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients
por: Kampylafka, Eleni I., et al.
Publicado: (2013) -
Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis
por: Kosmidis, Michalis L., et al.
Publicado: (2019)